Status:
COMPLETED
DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone
Lead Sponsor:
Medical University of South Carolina
Conditions:
Actinic Porokeratosis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study will analyze the effects of topical lovastatin/cholesterol vs topical lovastatin alone in patients with disseminated superficial actinic porokeratosis. Patients will be divided into two gro...
Detailed Description
The purpose of this study is to evaluate the effectiveness of cholesterol/lovastatin versus lovastatin alone to treat porokeratosis. Our working hypothesis is that both topical cholesterol/lovastatin ...
Eligibility Criteria
Inclusion
- All patients 18 years and older with the diagnosis of disseminated superficial actinic porokeratosis.
Exclusion
- Patients with allergies or contraindications to lovastatin or cholesterol
- Female patients currently pregnant or lactating.
- Female patients with plans to become pregnant.
- Patients actively taking approved forms of long-term contraception (oral contraceptives, implantable intrauterine devices, or other hormone eluting implants) will be allowed to participate as long as they have no plan to become pregnant during the course of the study. A urine pregnancy test will be administered to these patients to confirm that they can be included in the study.
- Inability or unwillingness of subject or legal guardian/representative to give informed consent
Key Trial Info
Start Date :
August 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 23 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04359823
Start Date
August 24 2020
End Date
April 23 2021
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425